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AbstrACt
Objective To evaluate the costs, benefits and cost-
effectiveness of complex workplace dietary interventions, 
involving nutrition education and system-level dietary 
modification, from the perspective of healthcare providers 
and employers.
Design Single-study economic evaluation of a cluster-
controlled trial (Food Choice at Work (FCW) study) with 
1-year follow-up.
setting Four multinational manufacturing workplaces in 
Cork, Ireland.
Participants 517 randomly selected employees (18–65 
years) from four workplaces.
Interventions Cost data were obtained from the FCW 
study. Nutrition education included individual nutrition 
consultations, nutrition information (traffic light menu 
labelling, posters, leaflets and emails) and presentations. 
System-level dietary modification included menu 
modification (restriction of fat, sugar and salt), increase 
in fibre, fruit discounts, strategic positioning of healthier 
alternatives and portion size control. The combined 
intervention included nutrition education and system-level 
dietary modification. No intervention was implemented in 
the control.
Outcomes The primary outcome was an improvement in 
health-related quality of life, measured using the EuroQoL 
5 Dimensions 5 Levels questionnaire. The secondary 
outcome measure was reduction in absenteeism, which is 
measured in monetary amounts. Probabilistic sensitivity 
analysis (Monte Carlo simulation) assessed parameter 
uncertainty.
results The system-level intervention dominated the 
education and combined interventions. When compared 
with the control, the incremental cost-effectiveness 
ratio (€101.37/quality-adjusted life-year) is less than 
the nationally accepted ceiling ratio, so the system-
level intervention can be considered cost-effective. The 
cost-effectiveness acceptability curve indicates there is 
some decision uncertainty surrounding this, arising from 
uncertainty surrounding the differences in effectiveness. 
These results are reiterated when the secondary outcome 
measure is considered in a cost–benefit analysis, whereby 
the system-level intervention yields the highest net benefit 
(€56.56 per employee).
Conclusions System-level dietary modification alone 
offers the most value per improving employee health-
related quality of life and generating net benefit for 
employers by reducing absenteeism. While system-level 
dietary modification strategies are potentially sustainable 
obesity prevention interventions, future research should 
include long-term outcomes to determine if improvements 
in outcomes persist.
trial registration number ISRCTN35108237; Post-
results.
IntrODuCtIOn 
The increasing prevalence of diet-related 
disease is a major contributor to global 
morbidity and mortality and also to esca-
lating healthcare spending.1 2 Calorie excess 
and dietary intakes of fat (saturated and trans 
fats), sugar and salt play a critical role in the 
development of many chronic diet-related 
diseases, including obesity, cardiovascular 
disease stroke and type 2 diabetes.3 In an 
effort to ease the health and economic burden 
of chronic diet-related disease, the work-
place has been identified as a priority setting 
to positively influence individuals’ dietary 
behaviours with individuals now spending up 
to two-thirds of their waking hours at work.3 4 
Owing to limited evidence on the effective-
ness of workplace dietary interventions and 
the need to integrate health effectiveness 
evidence with economic costs, an investiga-
tion of their cost-effectiveness is needed.5–8 
strengths and limitations of this study
 ► This is the first study to comprehensively integrate 
health effectiveness evidence with the economic 
costs of implementing and delivering workplace 
dietary interventions.
 ► The inclusion of a cost–benefit analysis which 
monetised absenteeism, facilitated the translation 
of trial outcomes into realisable benefits for 
businesses.
 ► The main limitation of this study is that it did not 
include long-term outcomes. Therefore, the potential 
for costs to be offset in the future is unknown.
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When estimating the cost-effectiveness of a workplace 
intervention, it is imperative that consideration is given 
to clinical and quality of life measures, and towards 
measuring the impact of the intervention on absen-
teeism. Employers bear the financial burden of diet-re-
lated diseases through workplace absenteeism which 
incurs both direct and indirect costs.9–14 Direct costs 
include sick pay schemes, medical referrals and the cost 
associated with replacing absent employees and indirect 
costs consist primarily of losses incurred through absen-
teeism which in turn leads to reduced productivity.15 In 
the UK alone, workplace absenteeism is estimated to cost 
£29 billion annually with a reported 131 million days lost to 
absenteeism in 2013.16 In an effort to halt these mounting 
costs, many employers are investing in workplace health 
promotion programmes; however, evidence on the cost-ef-
fectiveness of these programmes is limited.17 18 Further-
more, recent research has revealed that when investing in 
workplace health promotion, employers are also driven 
by altruistic motives and feel responsible for enabling the 
health of their employees.19 20 Employers feel responsible 
for creating a healthy workplace environment that will 
meet their employees’ growing expectations, which will 
help employee attract and retain employees.19 20 Simi-
larly, employers have become increasingly concerned 
with portraying a positive company image to industry and 
to their employees and perceive the implementation of 
workplace health interventions as a means of achieving 
this image.19 21
The Food Choice at Work (FCW) study was a clus-
ter-controlled trial of complex workplace dietary inter-
ventions.22 The novel trial assessed the comparative 
effectiveness of a system-level dietary modification inter-
vention and a nutrition education intervention both 
alone and in combination versus a control workplace. 
The findings demonstrate that a well-structured, complex 
workplace dietary intervention, combining nutrition 
education and system-level dietary modification, reduces 
employee’s dietary intakes of salt and saturated fat, 
improves employees’ nutrition knowledge and decreases 
their body mass index.5 Thus, combining nutrition educa-
tion and system-level dietary modification is an effective 
approach for promoting a healthy diet and weight loss 
at work. This study employed standard economic evalu-
ation methodology and evidence from the FCW trial to 
assess the cost-effectiveness of complex workplace dietary 
interventions. Cost-effectiveness of this complex work-
place dietary intervention was assessed from two different 
perspectives: (1) the health system perspective in terms of 
quality-adjusted life-years (QALYs), that is, a cost–utility 
analysis and (2) an employer’s perspective in terms of 
monetary benefit, that is, a cost–benefit analysis.
MethODs
This analysis follows the standard methodology of cost-ef-
fectiveness analysis and builds on previous analysis of 
workplace interventions to reduce absenteeism in the 
workplace.5 23 The methods and data used are explained 
with a more detailed description of modelling assump-
tions given.
Interventions
Full details of the FCW study have been described else-
where.5 22 Briefly, a cluster controlled trial was conducted 
in four large manufacturing workplaces in Cork, Ireland 
for a 9-month time period. Workplaces were allocated to 
receive one of the following: nutrition education alone 
(education) (n=226); system-level dietary modifica-
tion alone (system-level) (n=113); combined interven-
tion (combined) (n=400) or no intervention (control) 
(n=111). The number of employees recruited per work-
place was proportionate to company size.5 The nutrition 
education intervention was provided using individual 
nutrition consultations, group presentations and detailed 
nutrition education (traffic light menu labelling, posters, 
leaflets and e-mails). In the system-level intervention, 
dietary modification elements were implemented which 
included menu modification (restriction of fat, sugar 
and salt), an increase in fibre, fruit and vegetables, price 
discounts on fruit, strategic positioning of healthier 
alternatives and portion size control. The combined 
intervention included received all elements of the educa-
tion and system-level interventions and no intervention 
was implemented in the control.5 Table 1 contains a 
detailed description of the multicomponent intervention 
elements.
economic evaluation
This economic evaluation was primarily informed by 
national guidelines.24 Given the nature and scope of the 
intervention, a health service provider and employer’s 
perspective was taken. A cost–utility analysis measured the 
cost-effectiveness of the interventions in terms of QALYs 
and a cost–benefit analysis was employed, whereby the 
monetary value of absenteeism was used to estimate the 
net benefit of each intervention relative to the control.
Costs
A cost analysis of the FCW trial has been described else-
where.25 In summary, a bottom-up approach using micro-
costing was employed, whereby intervention costs were 
disaggregated from the employer’s perspective. The FCW 
research team involved in the development and imple-
mentation of the interventions were consulted to iden-
tify, measure and value the resources consumed under 
each intervention. The costs were classified into three 
different phases, representing setup costs, maintenance 
costs and physical assessment costs. Five cost categories 
were identified for each phase: (1) nutritionist costs; (2) 
catering costs; (3) management costs; (4) employee costs 
and (5) printing and material costs. Following identifica-
tion of the resources consumed in each intervention, the 
unit costs of the resources were multiplied by the quan-
tities used. Costs were valued in monetary terms using 
standard techniques in line with national guidelines.23 24 
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A detailed exposition of the costs and approaches used 
to estimate and value resources are fully described else-
where.25 Table 2 contains a breakdown of the total cost of 
the FCW interventions over 12 months. Total costs were 
standardised for a cohort of 517 employees per work-
place, which reflected the number of employees that 
completed the trial. Standardising costs for a 12-month 
period and for a cohort of 517 employees per workplace 
will increase the comparability of findings for employers. 
In addition, having the same sample size per workplace 
will allow employers to use the costs as a benchmark for 
similarly sized workplaces. Total costs were highest in the 
combined intervention (€52 940), followed by the educa-
tion intervention (€50 216) and the system-level inter-
vention (€25 345). In the control, physical assessment 
costs (monitoring of employees) accounted for 100% of 
costs (€22 201). All resource quantities and costs were 
estimated and reported in 2016 € (Ireland). Discounting 
was not undertaken due to the 1-year time horizon.
Outcomes
The primary outcome measure was an improvement in 
QALYs from baseline to 7–9-month follow-up. To measure 
health-related quality of life (HRQoL) the EuroQoL 5 
Dimensions 5 Levels  questionnaire was employed, as per 
national guidelines.24 As data were only available for 7–9 
months, HRQoL was extrapolated from 9 to 12 months to 
obtain HRQoL for a 1-year period, with the assumption 
that HRQoL remained constant for 12 months. In the 
absence of value set for Ireland, the UK cross-walk value 
set was employed to estimate QALYs.26
The secondary outcome measure was the net benefit 
of the interventions in terms of reducing absenteeism. 
Annual absence data for a year prior to and a year postin-
tervention implementation were obtained from the 
human resources department of each workplace. The 
monetary value of absenteeism was employed to report 
the net benefit of the interventions compared with the 
control. Reductions in absenteeism were valued using 
Table 1 Description of the intervention elements
Intervention Description of elements
Nutrition 
education
Group presentations: Monthly nutrition sessions (30 min per session) were delivered in the workplace by 
the FCW nutritionist. Topics included portion control, food labelling and general healthy eating guidelines. 
Sessions were repeated to ensure they were accessible to employees on different shift cycles.
Individual nutrition consultations: Participants received one-to-one dietary counselling with the FCW 
nutritionist. Consultations were tailored for each participant based on their lifestyle, physical assessment 
results and dietary recall assessments. The nutritionist provided advice on how to follow a healthy diet, 
reach/maintain a healthy body weight and achieve healthy resting blood pressure. Participants also received 
a healthy eating booklet and a personalised measurement card.
Detailed nutrition information: Detailed nutrition information was prepared by the FCW nutritionist and 
displayed in the workplace throughout the intervention. The information included posters, leaflets, e-mails 
and daily calorie menu labelling with a unique traffic light coding system. A healthy eating chat table was also 
provided twice a month during break times to provide employees with an opportunity to ask the nutritionist 
about healthy eating.
Environmental 
dietary 
modification
Menu modification: Fat, saturated fat, sugar and salt were restricted. Stock and bouillon were replaced with 
low-salt stock options. Salt was replaced with fresh herbs, spices and garlic for additional flavour. High-
salt savoury options, high-salt products and processed meats were reduced and replaced where possible 
with low-salt options. Full-fat dairy products were replaced with low-fat options where possible. Cream and 
cheese were not used as a garnish on meals and the amount of cheddar in all meals was reduced. Cooking 
methods using oil (deep-fat frying) were limited and replaced with boiling, poaching, grilling, baking and 
steaming where possible. Plant oils were introduced for cooking. Sauces and accompaniments were not 
added to any meal unless requested by the employee. Chips and French fries were removed from the menus 
2 days a week and were replaced with different potato options such as baked potatoes. Soft carbonated 
drinks were restricted and replaced with water, milk and unsweetened options.
Increase in fibre and availability of fruit and vegetables: White pasta, rice and bread were replaced with 
wholegrain alternatives. Fruit and vegetables were added to rice, pasta, soup and meat dishes. Fresh whole 
fruit was made available throughout the day and a buffet-style fresh salad bar was available to accompany 
any dish on a daily basis.
Price discounts: Portions of whole fresh fruit were offered at discount prices on a daily basis within the 
confines of the pre-existing catering contract.
Strategic positioning of food: Healthier alternatives were strategically positioned throughout the workplace 
canteen. Healthy snacks, such as fresh fruit, dried nuts, seeds, brown sandwiches and brown soda bread 
were positioned at eye level at the entrance of the canteen and in the vending machines. Free-flowing salt 
and sugar were removed from tables and replaced with sachets. 
Portion size control: Standard serving tools were used to control portion size at mealtimes. Catering staff 
received training from the FCW nutritionist regarding strict portion size control.
FCW, Food Choice at Work. 
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national estimates of the national average daily cost of 
absenteeism (€144.48).27 Complete follow-up data were 
available for a total of 517 employees from the four work-
places, sociodemographic, health and lifestyle charac-
teristics of employees who completed the trial and are 
presented in table 3.5
Assessing cost-effectiveness and investigating uncertainty
Incremental cost-effectiveness ratios (ICERs) and net 
benefit were employed to assess the cost-effectiveness 
of each intervention using the primary and secondary 
outcomes for a cost–utility analysis and cost–benefit anal-
ysis, respectively.24 28 A probabilistic sensitivity analysis, 
using Monte Carlo simulation was performed to assess 
parameter uncertainty. Probability distributions were 
assigned to individual model parameters. As the cost 
data were non-negative, continuous data, they assumed 
gamma distributions and the outcomes assumed normal 
probability distributions.29 The Monte Carlo simula-
tion propagated uncertainty throughout the model and 
provided 10 000 different values for expected costs and 
expected outcomes associated with each intervention 
and the control. The average of the expected costs and 
effects were used to estimate net benefit and ICERs in 
the probabilistic model. These ICERs were plotted onto 
incremental cost-effectiveness planes, with the costs 
plotted in the north–south axis and the effects plotted on 
the east–west axis. A cost-effectiveness acceptability curve 
summarised decision uncertainty by graphically demon-
strating the probability of an intervention being cost-ef-
fective compared with the control using a range of ceiling 
ratios (€0 to €100 000/QALY).30 31
results
Cost–utility analysis
With regards to intervention costs per employee, the 
lowest cost per employee was observed in the control 
(€42.94), followed by the system-level intervention 
(€49.02), the education intervention (€97.13) and the 
combined intervention (€102.40). Meanwhile, each of 
the interventions delivered QALY improvements, the 
largest improvement was observed in the system-level 
intervention (+0.05 QALYs), followed by the education 
intervention (+0.03 QALYs), the combined intervention 
(+0.01 QALYs); while the control resulted in deteriora-
tion (−0.01 QALYs) (table 4).
Table 2 Costs of implementing and delivering the interventions for 12 months
Control
costs (€)
Education
costs (€)
System-level
costs (€)
Combined
costs (€)
Setup costs 
  Nutritionist – 600 2494 3225
  Catering costs – 41 490 490
  Management stakeholder costs – 103 103 103
  Printing and materials – 1019 85 1019
  Employee time – 53 53 53
  Subtotal – 1816 3225 4890
Maintaining costs 
  Nutritionist – 12 985 350 12 635
  Catering costs – 1573    – 1573
  Management stakeholders costs – 205 205 205
  Printing and materials – 282    – 282
  Employee time – 8241    – 8241
  Subtotal – 23 286 555 22 936
Physical assessments 
  Nutritionist 14 224 14 333 13 659 14 333
  Employee time 7977 10 781 7906 10 781
  Subtotal 22 201 25 114 21 565 25 114
  Total cost of intervention 22 201 50 216 25 345 52 940
  Cost per employee (n=517) per year 42.94 97.13 49.02 102.40
  Total cost of intervention (excluding 
physical assessments)
0 25 102 3780 27 826
  Cost per employee (n=517) per year 
(excluding physical assessments)
0 48.55 7.31 53.82
 o
n
 19 April 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019182 on 3 March 2018. Downloaded from 
5Fitzgerald S, et al. BMJ Open 2018;8:e019182. doi:10.1136/bmjopen-2017-019182
Open Access
Comparing the costs and QALY improvements, it is 
evident that the system-level intervention dominates both 
the education intervention and the combined interven-
tion, as it delivers greater benefit at a lower cost. While 
compared with the control, the system-level intervention 
delivers more benefit but at a greater cost, positioning it in 
the northeastern quadrant on a cost-effectiveness plane. 
The ICER of the system-level intervention compared with 
control, €101.37/QALY, is well below what is considered 
cost-effective nationally (€45 000/QALY). However, the 
incremental cost-effectiveness plane (figure 1) demon-
strates there is considerable uncertainty surrounding the 
existence and extent of differences in effectiveness between 
the system-level intervention and the control (95% range 
produced in the probabilistic sensitivity analysis produced 
a 95% range of −0.49 to +0.60.) This translates into deci-
sion uncertainty, presented on the cost-effectiveness 
acceptability curve (figure 2), with 58% probability of the 
system-level intervention being cost-effective compared 
with control. As the ceiling ratio increases beyond €100/
QALY, the probability of the system-level intervention 
being cost-effective increases while it falls for the control.
Cost–benefit analysis
As discussed above the secondary outcome measure 
for the study was absenteeism which is employed in a 
Table 3 Sociodemographic, health and lifestyle characteristics of employees who completed the trial
Total
n=517
N (%)
Control
n=67
N (%)
Education
n=107
N (%)
System level
n=71
N (%)
Combined
n=272
N (%)
Sociodemographic 
  Age group (years)
   18–29 44 (8.5) 11 (16.4) 13 (12.1) 7 (9.9) 13 (4.8)
   30–44 331 (64.0) 34 (50.7) 67 (62.6) 33 (46.5) 197 (72.4)
   45–65 142 (27.5) 22 (32.8) 27 (25.2) 31 (43.7) 62 (22.8)
  Gender
   Male 393 (76.0) 42 (62.7) 81 (75.7) 43 (60.6) 227 (83.5)
   Female 124 (24.0) 25 (37.3) 26 (24.3) 28 (39.4) 45 (16.5)
  Educational level
   None/primary/secondary 99 (19.1) 24 (35.8) 24 (22.4) 32 (45.1) 19 (7.0)
   Tertiary 418 (80.9) 43 (64.2) 83 (77.6) 39 (54.9) 253 (93.0)
  Marital status
   Married/cohabiting 375 (72.5) 46 (68.7) 74 (69.2) 50 (70.4) 205 (75.4)
   Separated/divorced/widowed 17 (3.3) 5 (7.5) 3 (2.8) 2 (2.8) 7 (2.6)
   Single/never married 125 (24.2) 16 (23.9) 30 (28.0) 19 (26.8) 60 (22.1)
  Job position
   Manager/supervisor 114 (22.1) 17 (25.4) 27 (25.2) 14 (19.7) 56 (20.6)
   Non-manager/non-supervisor 403 (77.9) 50 (74.6) 80 (74.8) 57 (80.3) 216 (79.4)
Health
  Body mass index (kg/m2)
   Normal weight 147 (28.4) 17 (25.4) 34 (31.8) 18 (25.4) 78 (28.7)
   Overweight 254 (49.1) 33 (49.3) 48 (44.9) 34 (47.9) 139 (51.1)
   Obese 116 (22.4) 17 (25.4) 25 (23.4) 19 (26.8) 55 (20.2)
Lifestyle
  Smoking status
   Never smoked 285 (55.1) 37 (55.2) 56 (52.3) 34 (47.9) 157 (57.7)
   Former smoker 161 (31.1) 24 (34.3) 30 (28.0) 26 (36.6) 82 (30.1)
   Current smoker 71 (13.7) 6 (9.0) 21 (19.6) 11 (15.5) 33 (12.1)
  Physical activity
   Low 228 (44.1) 53 (79.1) 50 (46.7) 38 (53.5) 87 (32.0)
   Moderate 136 (26.3) 9 (13.4) 30 (28.0) 18 (25.4) 79 (29.0)
   High 153 (29.6) 5 (7.5) 27 (25.2) 15 (21.1) 106 (39.0)
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cost–benefit analysis to assess cost-effectiveness from an 
employer’s perspective. As outlined above the lowest 
cost per employee was observed in the control (€42.94), 
followed by the system-level intervention (€49.02), the 
education intervention (€97.13) and the combined inter-
vention (€102.40). Similar to the QALY estimates, each 
of the interventions improved absenteeism; the largest 
improvement was observed in the combined intervention 
(−0.78 days), followed by the system-level intervention 
(−0.71) and the education intervention (−0.36 days), 
while the control resulted in increased absenteeism 
(+0.34 days) (table 4). The reduction in absenteeism 
is expressed in monetary amounts using the national 
daily cost of absenteeism per employee of €144.48. The 
control and nutrition education interventions had nega-
tive net benefits, that is, the costs of the intervention 
Table 4 Change in effectiveness in outcomes from baseline 1-year follow-up
Costs
(€)
Cost–utility analysis Cost–benefit analysis
QALYs
(SD) ICER
Absenteeism
(SD)
Absenteeism
(€)*
Net 
benefit†
Control 42.94 −0.01 (0.11) +0.34 (5.38) 49.12 −92.06
  Probabilistic 42.91 −0.01 (0.19) +0.36 (5.40) 
System level 49.02 +0.05 (0.11) €101.37/QALY‡ −0.71 (3.67) −102.58 53.56
  Probabilistic 48.99 +0.06 (0.19) €100.76/QALY −0.76 (3.66) 
  95th  percentile range (€35.84–€147.93) 
Education 97.13 +0.03 (0.12) Dominated by 
system level
−0.36 (4.67) −52.01 −45.12
  Probabilistic 97.06 +0.03 (0.14) −0.35 (4.63) 
Combined 102.40 +0.01 (0.09) Dominated by 
system level
−0.78 (5.43) −112.69 10.29
  Probabilistic 102.33 +0.01 (0.14) −0.79 (5.46) 
*Cost per absent day €144.48.27
†Net benefit=benefits (€)—costs (€).
‡System-level versus control: (incremental costs/incremental QALYs).
ICER,  Incremental cost-effectiveness ratio; QALYs, quality-adjusted life-years. 
Figure 1 Incremental cost-effectiveness plane of the system-level intervention compared with the control. The system-level 
intervention delivers more benefit (additional QALYs) but at a greater cost, positioning the ICER in the northeastern quadrant 
on the cost-effectiveness plane. The plane illustrates the uncertainty surrounding the existence and extent of differences in 
effectiveness between the system-level intervention and the control (95% range produced in the probabilistic sensitivity analysis 
produced a 95% range of −0.49 to +0.60.). ICE, incremental cost-effectiveness; ICER, incremental cost-effectiveness ratio; 
QALYs, quality-adjusted life-years.
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outweighed the benefits of reduced absenteeism. The 
system-level and combined interventions had positive net 
benefits, that is, the savings gained from reduced absen-
teeism were greater than the costs of the intervention. 
The system-level intervention had the highest net benefit, 
€53.56 per employee, and therefore dominates the other 
interventions. These results are consistent with those 
in the cost–utility analysis which measured outcomes in 
terms of QALYs.
DIsCussIOn
This study sought to determine the cost-effectiveness of a 
complex workplace dietary intervention, which included 
nutrition education and system-level dietary modification 
elements both alone and in combination versus a control 
workplace. The system-level intervention dominated 
the education and combined interventions as it deliv-
ered greater benefit (QALYs) at lower costs. Compared 
with the control, the system-level intervention also deliv-
ered greater QALYs at an additional cost. The low ICER 
suggests the intervention is cost-effective, nevertheless, 
there is considerable uncertainty surrounding the differ-
ence in effects. The cost-effectiveness of the system-
level intervention was reiterated when considering the 
secondary outcome measure (absenteeism measured in 
euros in a cost–benefit analysis) as it delivered highest net 
benefit.
The main strength of this economic evaluation is that 
it is one of the first studies to comprehensively integrate 
health effectiveness evidence with the economic costs of 
implementing and delivering workplace dietary inter-
ventions. The findings from the economic evaluation 
complement the findings from the FCW cluster controlled 
trial that suggests workplace dietary interventions can 
potentially improve employee health.5–8 Moreover, the 
study provides employers, public health policy-makers, 
national and international catering stakeholders and 
industry with robust cost-effectiveness evidence on work-
place dietary interventions. The inclusion of a cost–
benefit analysis is an additional significant strength of this 
novel study. The Medical Research Council advocate that 
if an intervention is proven to be effective as improving 
health behaviours of employees, it is more likely that the 
intervention will be implemented at scale if the outcomes 
are presented in a way that is of relevance to those who 
are bearing the costs of the intervention.32 Therefore, 
in instances where interventions are funded by private 
industry, it is imperative that the monetary net benefits 
are of relevance to the business. In this study, monetising 
absenteeism facilitated the translation of the FCW trial 
outcomes into realisable and tangible benefits for busi-
nesses. Although each intervention reported a positive 
net benefit, it should be noted that these results are 
reliant on the monetary estimate for absenteeism that was 
used. The daily estimate that was used was obtained from 
the Irish Business and Employers Confederation (IBEC) 
and adjusted for inflation (€144.48), as no other suitable 
estimate within the Irish context is currently available.27
The study captures the high initial cost of inter-
vention implementation without incorporating long-
term outcomes. Future research, which would include 
collecting data on long-term outcomes, may also quan-
tify further health and monetary benefits that were not 
captured in this economic evaluation. For instance, 
improving employees’ dietary behaviours is likely to affect 
the dietary behaviours of their families and also possibly 
their wider communities, generating positive externali-
ties. Furthermore, it is possible that the cost of sickness 
Figure 2 Cost-effectiveness acceptability curve of the system-level intervention compared with the control. At a ceiling 
ratio of €45 000/QALY, the system-level intervention has a 58% probability of being cost-effective when compared with the 
control. QALY, quality-adjusted life-year.
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has been underestimated as this study did not measure 
presenteeism. Presenteeism has been defined as being 
present at work despite being ill and it is estimated that 
productivity losses due to presenteeism are significantly 
higher than losses incurred from absenteeism.33 34 A 2016 
Global Corporate Challenge report, estimated that in the 
USA, employees were absent from work for an average 
of 4 days per year, while they were unproductive at work 
for 57.5 days per year.35 The report further estimated that 
absenteeism costs US employers US$150 billion annually 
while presenteeism costs were estimated at US$1500 billion 
annually.35 To estimate the true cost of sickness, future 
research should include measures for both absenteeism 
and presenteeism. It should also be noted that the cost–
benefit analysis might be capturing time preference as 
employers may place greater value on short-term costs 
and benefits of reducing absenteeism rather than those 
occurring in the future (improving employee health). As 
this study did not include long-term outcomes, which is its 
main limitation, the potential for costs to be offset in the 
future is unknown. Furthermore, the inclusion of atyp-
ical multinational manufacturing workplaces along with 
the small sample size, may potentially limit the general-
isability of the findings. Additionally, the potential pres-
ence of participation bias must be acknowledged. Despite 
employees being randomly selected to participate in the 
study, bias cannot be ruled out as healthy employees may 
have been more likely to participate in the study when 
compared with unhealthier employees.
From a public health policy perspective, there is 
a definite need for pragmatism in the assessment of 
low-risk interventions, such as those addressed in this 
study, in tackling societal challenges of obesity and poor 
dietary behaviours.13 As any single obesity prevention 
intervention is likely to have only a small impact at the 
aggregated level, there is a need to implement multiple 
low-agency interventions that do not require individuals 
to consciously engage with any intervention element 
of change their behaviour.36 This study suggests that 
despite the use of a short time frame, system-level dietary 
modification interventions can potentially offer the best 
value in terms of improving employee health and gener-
ating monetary benefit for employers through reducing 
absenteeism.
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